Type
Internal restructuring
Country
Spain
Region
Este; Catalu├▒a; Barcelona
Location of affected unit(s)
Barcelona
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.20 - Manufacture of pharmaceutical preparations

103 jobs
Number of planned job losses
Job loss
Announcement Date
30 October 2018
Employment effect (start)
Foreseen end date

Description

Spanish international pharmaceutical company Esteve has presented a collective dismissal plan, which affects 103 out of the 1,290 employees of the company in Spain. The figure represents 7 per cent of its workforce. The employees to be made redundant work in the administrative, commercial and R & D areas.

The causes argued by the company are the limited growth of the Spanish pharmaceutical market and the high investment costs required to continue the development of some of its products. Representatives of the trade union in the company rejected the plan and stated that the situation of the company does not justify the dismissals. It is the second collective layoff plan in the history of the company; the first one in 2013 lead to the dismissal of 225 employees.


Sources

Citation

Eurofound (2018), Esteve, Internal restructuring in Spain, factsheet number 96282, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/96282.